Deal strengthens Merit’s position in electrophysiology and global cardiac intervention markets.
Merit Medical Systems (Nasdaq: MMSI) has completed its $210 million acquisition of Cook Medical’s lead management portfolio, funded through cash on hand and long-term credit borrowings. This move bolsters Merit’s growing electrophysiology and cardiac rhythm management (CRM) business.
Expanding Electrophysiology Capabilities
Cook Medical’s lead management business offers devices for procedures involving pacemaker and implantable cardioverter-defibrillator (ICD) lead removal or replacement. Combined with Merit’s technologies for accessing and treating cardiac rhythm disorders, the acquisition enhances its offerings in the global cardiac intervention market.
Financial Impact
- Cook’s lead management portfolio generated $37 million in 2023 revenues.
- Merit anticipates $4–$6 million in additional revenue through 2024 but expects temporary dilution to non-GAAP metrics.
“We are excited to integrate Cook Medical’s talented team and believe this acquisition will strengthen our high-margin electrophysiology and CRM business,” said Fred P. Lampropoulos, Merit’s CEO.
With this acquisition, Merit continues to expand its portfolio, delivering innovative solutions to cardiac care professionals worldwide.
Follow MEDWIRE.AI for updates on MedTech acquisitions and innovations.
